IMPROVE-IT: Diabetics Benefit With Ezetimibe, but Is It Enough?IMPROVE-IT: Diabetics Benefit With Ezetimibe, but Is It Enough?

Diabetics saw reductions in MI and stroke with ezetimibe in a new analysis of IMPROVE-IT. But one expert said it's still not enough to convince him to use it; more refined risk assessment is needed. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news